Inicio>>Signaling Pathways>> DNA Damage/DNA Repair>> Checkpoint Kinase (Chk)>>MK-8776(SCH-900776)

MK-8776(SCH-900776) (Synonyms: MK-8776)

Catalog No.GC16374

MK-8776(SCH-900776) (MK-8776) es un inhibidor potente, selectivo y biodisponible por vÍa oral del punto de control quinasa 1 (Chk1) con una IC50 de 3 nM. MK-8776 (SCH-900776) muestra una selectividad de 50 y 500 veces sobre CDK2 y Chk2, respectivamente.

Products are for research use only. Not for human use. We do not sell to patients.

MK-8776(SCH-900776) Chemical Structure

Cas No.: 891494-63-6

Tamaño Precio Disponibilidad Cantidad
10mM (in 1mL DMSO)
82,00 $
Disponible
5mg
76,00 $
Disponible
10mg
118,00 $
Disponible
50mg
312,00 $
Disponible

Tel:(909) 407-4943 Email: sales@glpbio.com

Reseñas de cliente

Based on customer reviews.

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Protocol Chemical Properties Product Documents Related Products

SCH 900776 is a potent and selective inhibitor of cell cycle checkpoint kinase 1 (Chk1), Chk2 and Cdk3 with IC50 value of 3 nM, 1.5µM and 0.16 µM, respectively.

Chk is s serine/threonine kinase that senses signal of DNA damage and stalls DNA replication, and also plays an essential role in the maintenance of replication fork viability during exposure to DNA antimetabolites.

In vitro, SCH 900776 blocked accumulation of the Chk1 pS296 autophosphorylation in a dose-dependent manner. Treatment of proliferating WS1 cells with SCH 900776 was found to be associated with rapid, dose-dependent accumulation of Chk1 pS345, indicating that cycling populations of normal cells induce Chk1 pS345 in response to the inhibition of SCH 900776 as part of a futile cycle 1.

In BALB/c mice, administration of SCH 900776 at a dosage of 8mg/kg after gemcitabine treatment can sufficiently induce enhanced tumor pharmacodynamic and regression responses as compared to gemcitabine or SCH 900776 alone 1.

Reference:
1.   Guzi TJ, Paruch K, Dwyer MP, et al. Targeting the replication checkpoint using SCH 900776, a potent and functionally selective CHK1 inhibitor identified via high
content screening. Molecular cancer therapeutics. 2011;10(4):591-602.

Reseñas

Review for MK-8776(SCH-900776)

Average Rating: 5 ★★★★★ (Based on Reviews and 8 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for MK-8776(SCH-900776)

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.